Focal adhesion kinase family is involved in matrix contraction by transdifferentiated Müller cells
Rintaro Tsukahara1, Kazuhiko Umazume2, Kevin McDonald3
1Department of Ophthalmology and Visual Sciences, University of Louisville, 301 E Muhammad Ali Blvd., Louisville, KY 40202, USA; Department of Ophthalmology, Tokyo Medical University, Ibaraki Medical Center, 3-20-1 Chuo, Ami, Inashiki-gun, Ibaraki 300-0332, Japan.
Abstract:
Transdifferentiated Müller cells that adopt a fibroblastic/myofibroblastic phenotype have been identified in epiretinal membranes (ERMs) in several ocular disorders, and have been implicated to play a role in the formation and/or the contraction of ERMs. We have previously demonstrated that dasatinib, a dual inhibitor of Src-family kinases and Abl kinase, can prevent matrix contraction by transdifferentiated Müller cells. In this study, we examined molecules involved in matrix contraction downstream of primary dasatinib targets. Tyrosine phosphorylation of focal adhesion kinase (FAK) family members FAK and PYK2 was significantly reduced by dasatinib, and select inhibitors for these kinases PF431396, which inhibits both FAK and PYK2, and PF573228, which only inhibits FAK and not PYK2, significantly reduced matrix contraction by transdifferentiated Müller cells. Dasatinib and PF431396 significantly reduced phosphorylation of Hic-5, a protein implicated to play a role in focal adhesions and cell signaling. Our data shows that FAK family members are involved in matrix contraction by transdifferentiated Müller cells, and also implicates that Hic-5 is situated downstream of the FAK family within the signaling pathway.
Insights
Dasatinib and FAK/PYK2 inhibitors reduce matrix contraction in epiretinal membranes by targeting Müller cells. This study identifies focal adhesion kinase family members and Hic-5 as key players in this process.
Area of Science:
- Ophthalmology
- Cell Biology
- Biochemistry
Background:
- Transdifferentiated Müller cells with fibroblastic/myofibroblastic phenotypes contribute to epiretinal membrane (ERM) formation and contraction.
- Dasatinib, a dual Src-family and Abl kinase inhibitor, previously showed efficacy in preventing matrix contraction by these cells.
Purpose of the Study:
- To investigate molecules downstream of dasatinib's primary targets involved in matrix contraction.
- To elucidate the role of focal adhesion kinase (FAK) family members and Hic-5 in Müller cell-mediated matrix contraction.
Main Methods:
- Utilized dasatinib and specific inhibitors (PF431396, PF573228) targeting FAK family kinases (FAK, PYK2).
- Assessed the impact of these inhibitors on matrix contraction by transdifferentiated Müller cells.
- Measured tyrosine phosphorylation levels of FAK, PYK2, and Hic-5.
Main Results:
- Dasatinib significantly reduced tyrosine phosphorylation of FAK and PYK2.
- Inhibitors PF431396 (FAK/PYK2) and PF573228 (FAK-specific) markedly reduced matrix contraction.
- Dasatinib and PF431396 decreased Hic-5 phosphorylation, indicating its downstream position.
Conclusions:
- FAK family members (FAK and PYK2) are crucial mediators of matrix contraction in transdifferentiated Müller cells.
- Hic-5 is implicated as a downstream signaling molecule in the FAK-mediated pathway contributing to matrix contraction.
Related Concept Videos
Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...
Intracellular Signaling Affects Focal Adhesions
Some...
Overview of Cell-Matrix Interactions
Tension Response at Adherens Junctions
α-Catenin as a Mechanosensory Protein
The α-catenin of adherens junctions is an allosteric protein with three VH (vinculin...
Anchoring Junctions
Cell Migration


